Sponsor hub
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. clinical trial failures
Review 28 stopped clinical trials from Chia Tai Tianqing Pharmaceutical Group Co., Ltd., including disease areas, phases, and classified stop reasons.
This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 0 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.
Dominant stop reasons
- OPERATIONAL
- 18
- OTHER/UNKNOWN
- 10
Notable sponsors
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- 28
Related phases
- Phase I
- 18
- Phase II
- 10
Crawlable stopped-trial records
Open ExploreShowing up to 28 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.
Phase I Glucocorticoid-Refractory aGVHD trial by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Stop reason: OPERATIONAL.
This study was closed due to business reasons. Closure was not prompted by any safety or efficacy concerns.
Phase II Extensive Stage Small Cell Lung Cancer trial by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Stop reason: OPERATIONAL.
This study was closed due to business reasons. Closure was not prompted by any safety or efficacy concerns.
Phase II Advanced Lung Carcinoma trial by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Stop reason: OPERATIONAL.
This study was closed due to business reasons. Closure was not prompted by any safety or efficacy concerns.
Phase I Metastatic Castration-resistant Prostate Cancer trial by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Stop reason: OPERATIONAL.
Per sponsor request. Premature closure was not prompted by any safety or efficacy concerns.
Phase II Advanced Endometrial Cancer trial by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Stop reason: OPERATIONAL.
Per sponsor request. Premature closure was not prompted by any safety or efficacy concerns.
Phase I Myelofibrosis trial by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Stop reason: OPERATIONAL.
Per sponsor request. Premature closure was not prompted by any safety or efficacy concerns.
Phase I Breast Cancer trial by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Stop reason: OPERATIONAL.
This study was closed due to business reasons. Closure was not prompted by any safety or efficacy concerns.
Phase I Advanced Hepatocellular Carcinoma trial by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Stop reason: OPERATIONAL.
This study was closed due to business reasons. Closure was not prompted by any safety or efficacy concerns.
Phase II Dedifferentiated Liposarcoma trial by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Stop reason: OPERATIONAL.
This study was closed due to business reasons. Closure was not prompted by any safety or efficacy concerns.
Phase I Myelofibrosis trial by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Stop reason: OPERATIONAL.
This study was closed due to business reasons. Closure was not prompted by any safety or efficacy concerns.
Phase I Advanced Hepatocellular Carcinoma trial by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Stop reason: OPERATIONAL.
This study was closed due to business reasons. Closure was not prompted by any safety or efficacy concerns
Phase II Chronic Hepatitis B trial by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Stop reason: OPERATIONAL.
Per sponsor request. Premature closure was not prompted by any safety or efficacy concerns.
Phase I Advanced Esophageal Squamous Cell Carcinoma trial by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Stop reason: OPERATIONAL.
This study was closed due to business reasons. Closure was not prompted by any safety or efficacy concerns.
Phase II Chronic Obstructive Pulmonary Disease (COPD) trial by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Stop reason: OPERATIONAL.
Per sponsor request. Closure was not prompted by any safety or efficacy concerns.
Phase II Rheumatoid Arthritis trial by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Stop reason: OPERATIONAL.
Per sponsor request.
Phase I Allergic Rhinitis trial by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Stop reason: OPERATIONAL.
This study was closed per sponsor request. Premature closure was not prompted by any safety or efficacy concerns.
Phase I Advanced Cancer trial by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Stop reason: OPERATIONAL.
Per sponsor request.
Phase I Advanced Malignant Neoplasm trial by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Stop reason: OTHER/UNKNOWN.
Based on the current status of the same target research and the company's overall layout in the field of tumors, the early termination was determined after full communication with the principal investigator of the group leader unit.
Phase I Non Small Cell Lung Cancer trial by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Stop reason: OTHER/UNKNOWN.
After considering the company's project situation and strategic development direction, it has been decided to terminate this project. The experiment will be terminated for non safety reasons.
Phase I Neurofibromatosis and Malignant Peripheral Nerve Sheath Tumors trial by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Stop reason: OTHER/UNKNOWN.
sponsor adjusts its research and development strategy
Phase I Advanced Cancer trial by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Stop reason: OTHER/UNKNOWN.
The sponsor has decided to terminate this study based on the current clinical research status of dual antibody drugs and full communication with the investigators.
Phase I Advanced Malignant Neoplasm trial by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Stop reason: OTHER/UNKNOWN.
The sponsor voluntarily withdraw the project.
Phase I Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma trial by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Stop reason: OTHER/UNKNOWN.
The sponsor terminated the study due to the R\&D strategy change.
Phase II Cervical Cancer trial by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Stop reason: OTHER/UNKNOWN.
Slow progress in development, the sponsor decided to withdraw and no longer proceed.
Phase I Metastatic Castration-resistant Prostate Cancer trial by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Stop reason: OTHER/UNKNOWN.
The sponsor voluntarily terminated the study
Phase I Non-small Cell Lung Cancer trial by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Stop reason: OPERATIONAL.
The enrolment task cannot be gotten within the planned time.It mainly includes patients with non-small cell lung cancer failed in standard treatment,with a short survival period.It is hard to obtain observational endpoints for bone-related events.
Phase II Relapsed or Refractory Primary Mediastinal B-cell Lymphoma (rrPMBCL) trial by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Stop reason: OTHER/UNKNOWN.
The population of target indication is small and screening is difficult.
Phase II Chronic Obstructive Pulmonary Disease trial by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.